RCN2 and nasopharyngeal carcinoma: We further evaluated the prognostic value and found that combined use of the three biomarkers were significantly associated with OS (Fig. 8P), and these findings suggest that high expression of RCN2 in combination with high expression of GSC and YY1 may serve as an important clinical biomarker of poor prognosis in patients with NPC.